Wednesday, February 10, 2010, 4:48pm SGT - The Singapore stock market closes in 12 minutes.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

GlaxoSmithKline plc (GSK)

At 5:00AM SGT: 38.47 USD   0.00 (0.00%)  
 MORE ON GSK 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 GLAXOSMITHKLINE PLC (NYSE:GSK) Delayed quote dataEdit
Last Trade:38.47 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:38.47
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:42.23
Day's Range:N/A - N/A
52wk Range:27.15 - 43.47
Volume:0
Avg Vol (3m):1,788,550
Market Cap:97.52B
P/E (ttm):12.37
EPS (ttm):3.11
Div & Yield:1.86 (4.82%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add GSK to Portfolio   Download Data

 HEADLINES 
•Bone Up On This Potential Blockbuster
at Motley Fool (Wed 12:58am)
•Europe Launches Probe into Pharma Deals
at BusinessWeek (Tue 11:52pm)
•Germany Cancels Swine Flu Vaccines
at BusinessWeek (Tue 11:52pm)
•Glaxo considering job cuts at UK research center
AP (Tue 11:41pm)
•Biotech Deal-Making Crosses Borders as Capital Markets Slide
at Seeking Alpha (Tue 5:32pm)
•Dynavax starts hepatitis B trial
at bizjournals.com (Tue 9:05am)
•Popular antidepressant interferes with cancer drug
at Reuters (Tue 8:00am)
•Vitaliy Katsenelson Reveals "The Perfect Stock for This Economy"
TechTicker (Tue 1:43am)
•UPDATE - Roche licenses new flu-fighting technology
at Reuters (Tue 12:18am)
•GlaxoSmithKline, Poniard, Protalix Provide Biotech's Latest Mishaps
at Seeking Alpha (Mon, Feb 8)
•How Big Pharma Got in This Fix
at Seeking Alpha (Sun, Feb 7)
•Believe In The Market's Healthy Skepticism
at Forbes.com (Sat, Feb 6)
•Big Pharma's Shot In The Arm
at CNBC (Sat, Feb 6)
•Vaccines Drive Glaxo's Revenues
Zacks.com (Fri, Feb 5)
•Business Highlights
AP (Fri, Feb 5)
More Headlines for GSK...
 ANALYST 
EPS Est (next year) (Dec-09) :3.86
EPS Est (in 2 years) (Dec-10) :3.48
Avg Rec (current)*:3.3
PEG Ratio:2.65
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, over the counter (OTC) medicines, and health related consumer products.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices